Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Omnicare CR Becomes Theorem Clinical Research | Contract Pharma
Breaking News

Omnicare CR Becomes Theorem Clinical Research

Omnicare Clinical Research is re-branding as Theorem Clinical Research. The brand launch follows Nautic Partners, LLC’s acquisition of Omnicare CR in April from former parent company, Omnicare, Inc.

Omnicare Clinical Research is re-branding as Theorem Clinical Research. The brand launch follows Nautic Partners, LLC’s acquisition of Omnicare CR in April from former parent company, Omnicare, Inc.

Theorem Clinical Research will continue to provide full-service clinical trial management, with a continued focus on its core CRO operations — Early Phase, Phase II/III, Late Phase — and its specialized business units: Pharmaceutics, Medical Device, and Technical Services (Biometrics & Clinical Data Management). Theorem has 1,000 employees with locations in 32 countries.

“The re-branding of the company is not something that happened overnight,” said Dr. James Pusey, president and chief executive officer of Theorem Clinical Research. “This is 25 years in the making. We are now able to be more agile and efficient since we are now in the driver’s seat of our own company. We strive to be able to work the way our clients do; from our specialized business units to our 32 locations, Theorem Clinical Research is able to give clients exactly what they need.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters